Sousan S. Altaie

Dr. Sousan S. Altaie is Scientific Policy Advisor for the Office of In Vitro Diagnostic Devices in the United States. She joined the Food and Drug Administration in the Center for Drug Evaluation and Research in the Division of Anti-infective Drug Products as a primary reviewer in 1995.[1][2][3] Six years later she joined the FDA's Center for Devices and Radiological Health as the Chief of Immunology and Molecular Diagnostics Branch. She is actively working as a member of the Global Harmonization Task Force (GHTF) and International Organisation for Standardisation (ISO) working groups. She was appointed the CDRH Critical Path Coordinator in 2004 and is actively involved in the Agency's Critical Path initiative. She has served as an observer, advisor and full member of various committees and subcommittees of the Clinical and Laboratory Standards Institute (CLSI).

Altaie has been an active member of the Washington DC Branch of the American Society of Microbiology, serving as the Counselor, President elect and the President. She completed a two-year Fellowship in Medical Microbiology at the Medical College of Virginia in Richmond, prior to joining the Department of Pediatrics, Division of Infectious Diseases at the State University of New York as an Assistant Professor, and also was appointed Director of Bacteriology and Serology Laboratories at the Children's Hospital of Buffalo. Her research interest is in the transplacental transmission of Lyme disease and she is the author of many peer-reviewed articles. Altaie received her PhD in Clinical Microbiology and Immunology from the University of North Texas in Denton.

References

  1. ↑ "Presentations from Meetings". 2006 Educational Conference. September 14, 2006. Retrieved 2010-01-18. Sousan Altaie, Ph.D. FDA
  2. ↑ Sousan S. Altaie (2000). "Augmentin ES -- Clinical Microbiology Review". Google Docs. Retrieved 2010-01-18.
  3. ↑ "AMDM/FDA - OIVD 510(k) Workshop". FDA. April 23, 2008. Retrieved 2010-01-18. re-IDE * Sousan Altaie, PhD, Scientific Policy Advisor, OD, OIVD
This article is issued from Wikipedia - version of the 11/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.